NCT00778154View on ClinicalTrials.gov

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Postmenopausal Osteoporosis
Trial Locations (8)

19610

Warner Chilcott Research Facility, Wyomissing

30033

Warner Chilcott Research Facility, Decatur

30501

Warner Chilcott Research Facility, Gainesville

45219

Warner Chilcott Research Facility, Cincinnati

68131

Warner Chilcott Research Facility, Omaha

80227

Warner Chilcott Research Facility, Lakewood

92269

Warner Chilcott Research Facility, Palm Desert

H2X 1P1

Warner Chilcott Research Facility, Montreal

Sponsors

Lead Sponsor

Warner Chilcott

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Warner Chilcott

INDUSTRY

NCT00778154 - Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate | Biotech Hunter | Biotech Hunter